Pulmonary surfactant and prostaglandin E
Guinea Pigs
Animals
Humans
Male
Muscle, Smooth
/ drug effects
Muscle Relaxation
/ drug effects
Dinoprostone
/ pharmacology
Pulmonary Surfactants
/ metabolism
Trachea
/ drug effects
Receptors, Prostaglandin E, EP2 Subtype
/ metabolism
Cells, Cultured
Receptors, Prostaglandin E, EP4 Subtype
/ metabolism
airway smooth muscle
atomic force microscopy
prostaglandin E2
pulmonary surfactant
relaxation
Journal
Physiological reports
ISSN: 2051-817X
Titre abrégé: Physiol Rep
Pays: United States
ID NLM: 101607800
Informations de publication
Date de publication:
Sep 2024
Sep 2024
Historique:
revised:
12
08
2024
received:
18
05
2024
accepted:
22
08
2024
medline:
9
9
2024
pubmed:
9
9
2024
entrez:
8
9
2024
Statut:
ppublish
Résumé
Pulmonary surfactant serves as a barrier to respiratory epithelium but can also regulate airway smooth muscle (ASM) tone. Surfactant (SF) relaxes contracted ASM, similar to β
Substances chimiques
Dinoprostone
K7Q1JQR04M
Pulmonary Surfactants
0
Receptors, Prostaglandin E, EP2 Subtype
0
Receptors, Prostaglandin E, EP4 Subtype
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e70026Subventions
Organisme : Agentúra na Podporu Výskumu a Vývoja (APVV)
ID : APVV-17-0250
Organisme : Vedecká Grantová Agentúra MŠVVaŠ SR a SAV (VEGA)
ID : VEGA 1/0055/19
Organisme : Ministerstvo školstva, vedy, výskumu a športu SR | Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR (Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic for the Structural Funds of EU)
ID : 26246
Organisme : Ministerstvo školstva, vedy, výskumu a športu SR | Agentúra Ministerstva Školstva, Vedy, Výskumu a Športu SR (Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic for the Structural Funds of EU)
ID : 34237
Organisme : University of Calgary (U of C)
Informations de copyright
© 2024 The Author(s). Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.
Références
Adriaensen, D., Brouns, I., Pintelon, I., de Proost, I., & Timmermans, J. P. (1985). Evidence for a role of neuroepithelial bodies as complex airway sensors: Comparison with smooth muscle‐associated airway receptors. Journal of Applied Physiology, 101(960–970), 2006–2970. https://doi.org/10.1152/JAPPLPHYSIOL.00267.2006
Amrein, M. W., & Stamov, D. (2019). Atomic force microscopy in the life sciences. Springer.
An, S. S., Fabry, B., Trepat, X., Wang, N., & Fredberg, J. J. (2012). Do biophysical properties of the airway smooth muscle in culture predict airway hyperresponsiveness? American Journal of Respiratory Cell and Molecular Biology, 35, 55–64. https://doi.org/10.1165/RCMB.2005‐0453OC
An, S. S., Laudadio, R. E., Lai, J., Rogers, R. A., & Fredberg, J. J. (2002). Stiffness changes in cultured airway smooth muscle cells. American Journal of Physiology. Cell Physiology, 283, 792–801. https://doi.org/10.1152/AJPCELL.00425.2001
An, S. S., Mitzner, W., Tang, W. Y., Ahn, K., Yoon, A. R., Huang, J., Kilic, O., Yong, H. M., Fahey, J. W., Kumar, S., Biswal, S., Holgate, S. T., Panettieri, R. A., Solway, J., & Liggett, S. B. (2016). An inflammation‐independent contraction mechanophenotype of airway smooth muscle in asthma. The Journal of Allergy and Clinical Immunology, 138, 294–297. https://doi.org/10.1016/J.JACI.2015.12.1315
Avery, M. E., & Mead, J. (1959). Surface properties in relation to atelectasis and hyaline membrane disease. The American Journal of Diseases of Children, 97, 517–523. https://doi.org/10.1001/ARCHPEDI.1959.02070010519001
Babu, K. S., Woodcock, D. A., Smith, S. E., Staniforth, J. N., Holgate, S. T., & Conway, J. H. (2003). Inhaled synthetic surfactant abolishes the early allergen‐induced response in asthma. European Respiratory Journal, 21, 1046–1049. https://doi.org/10.1183/09031936.03.00069202
Bailey, T. C., & Veldhuizen, R. A. W. (2005). The physiological significance of a dysfunctional lung surfactant (1st ed.). CRC Press.
Banerjee, R., & Puniyani, R. R. (2000). Exogenous surfactant therapy and mucus rheology in chronic obstructive airway diseases. Journal of Biomaterials Applications, 14, 243–272. https://doi.org/10.1177/088532820001400304
Barnes, P. J. (2002). Asthma and COPD: Basic mechanisms and clinical management. Academic Press.
Barnes, P. J. (2012). Pharmacology of airway smooth muscle. American Journal of Respiratory and Critical Care Medicine, 158, 123–132. https://doi.org/10.1164/AJRCCM.158.SUPPLEMENT_2.13TAC800
Bärnthaler, T., Maric, J., Platzer, W., Konya, V., Theiler, A., Hasenöhrl, C., Gottschalk, B., Trautmann, S., Schreiber, Y., Graier, W. F., Schicho, R., Marsche, G., Olschewski, A., Thomas, D., Schuligoi, R., & Heinemann, A. (2017). The role of PGE2 in alveolar epithelial and lung microvascular endothelial crosstalk. Scientific Reports, 7, 7923. https://doi.org/10.1038/S41598‐017‐08228‐Y
Becher, G. (1985). Lung surfactant prevents allergic bronchial constriction in ovalbumin sensitized Guinea pigs. Biomedica Biochimica Acta, 44, 57–61.
Bernal, A. L., Newman, G. E., Phizackerley, P. J. R., & Turnbull, A. C. (1988). Surfactant stimulates prostaglandin E production in human amnion. British Journal of Obstetrics and Gynaecology, 95, 1013–1017. https://doi.org/10.1111/J.1471‐0528.1988.TB06506.X
Blanco, O., Ramírez, W., Lugones, Y., Díaz, E., Morejón, A., Rodríguez, V. S., Alfonso, W., & Labrada, A. (2022). Protective effects of Surfacen® in allergen‐induced asthma mice model. International Immunopharmacology, 102, 1–9. https://doi.org/10.1016/J.INTIMP.2021.108391
Brandsma, J., Schofield, J. P. R., Yang, X., Strazzeri, F., Barber, C., Goss, V. M., Koster, G., Bakke, P. S., Caruso, M., Chanez, P., Dahlén, S. E., Fowler, S. J., Horváth, I., Krug, N., Montuschi, P., Sanak, M., Sandström, T., Shaw, D. E., Chung, K. F., … Djukanović, R. (2023). Stratification of asthma by lipidomic profiling of induced sputum supernatant. Journal of Allergy and Clinical Immunology, 152, 117–125. https://doi.org/10.1016/J.JACI.2023.02.032
Buckley, J., Birrell, M. A., Maher, S. A., Nials, A. T., Clarke, D. L., & Belvisi, M. G. (2011). EP4 receptor as a new target for bronchodilator therapy. Thorax, 66, 1029–1035. https://doi.org/10.1136/THX.2010.158568
Calhoun, W. J., & Chupp, G. L. (2022). The new era of add‐on asthma treatments: Where do we stand? Allergy, Asthma and Clinical Immunology, 18, 1–13. https://doi.org/10.1186/S13223‐022‐00676‐0
Calkovska, A., Uhliarova, B., Joskova, M., Franova, S., Kolomaznik, M., Calkovsky, V., & Smolarova, S. (2015). Pulmonary surfactant in the airway physiology: A direct relaxing effect on the smooth muscle. Respiratory Physiology & Neurobiology, 209, 95–105. https://doi.org/10.1016/j.resp.2015.01.004
Carreto‐Binaghi, L. E., Aliouat, E. M., & Taylor, M. L. (2016). Surfactant proteins, SP‐A and SP‐D, in respiratory fungal infections: Their role in the inflammatory response. Respiratory Research, 17, 1–7. https://doi.org/10.1186/S12931‐016‐0385‐9
Deshpande, D. A., Wang, W. C. H., McIlmoyle, E. L., Robinett, K. S., Schillinger, R. M., An, S. S., Sham, J. S. K., & Liggett, S. B. (2010). Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nature Medicine, 16, 1299–1304. https://doi.org/10.1038/nm.2237
Elson, E. L. (1988). Cellular mechanics as an indicator of cytoskeletal structure and function. Annual Review of Biophysics and Biophysical Chemistry, 17, 397–430. https://doi.org/10.1146/ANNUREV.BB.17.060188.002145
Enhorning, G., Duffy, L. C., & Welliver, R. C. (1995). Pulmonary surfactant maintains patency of conducting airways in the rat. American Journal of Respiratory and Critical Care Medicine, 151, 554–556. https://doi.org/10.1164/AJRCCM.151.2.7842219
Enhorning, G., Hohlfeld, J., Krug, N., Lema, G., & Welliver, R. C. (2000). Surfactant function affected by airway inflammation and cooling: Possible impact on exercise‐induced asthma. European Respiratory Journal, 15, 532–538. https://doi.org/10.1034/J.1399‐3003.2000.15.17.X
Feo‐Lucas, L., Godio, C., Minguito de la Escalera, M., Alvarez‐Ladrón, N., Villarrubia, L. H., Vega‐Pérez, A., González‐Cintado, L., Domínguez‐Andrés, J., García‐Fojeda, B., Montero‐Fernández, C., Casals, C., Autilio, C., Pérez‐Gil, J., Crainiciuc, G., Hidalgo, A., López‐Bravo, M., & Ardavín, C. (2023). Airway allergy causes alveolar macrophage death, profound alveolar disorganization and surfactant dysfunction. Frontiers in Immunology, 14, 1–14. https://doi.org/10.3389/FIMMU.2023.1125984
Fujii, S., Suzuki, K., Kawamoto, A., Ishibashi, F., Nakata, T., Murano, T., Ito, G., Shimizu, H., Mizutani, T., Oshima, S., Tsuchiya, K., Nakamura, T., Araki, A., Ohtsuka, K., Okamoto, R., & Watanabe, M. (2016). PGE2 is a direct and robust mediator of anion/fluid secretion by human intestinal epithelial cells. Scientific Reports, 6, 1–15. https://doi.org/10.1038/srep36795
Goerke, J., & Clements, J. A. (2011). Alveolar surface tension and lung surfactant. In Comprehensive physiology (pp. 247–261). John Wiley & Sons, Ltd.
Griese, M., Birrer, P., & Demirsoy, A. (1997). Pulmonary surfactant in cystic fibrosis. European Respiratory Journal, 10, 1983–1988. https://doi.org/10.1183/09031936.97.10091983
Günther, A., Siebert, C., Schmidt, R., Ziegler, S., Grimminger, F., Yabut, M., Temmesfeld, B., Walmrath, D., Morr, H., & Seeger, W. (2012). Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. American Journal of Respiratory and Critical Care Medicine, 153, 176–184. https://doi.org/10.1164/AJRCCM.153.1.8542113
Hagberg, C. A. (2013). Benumof and Hagberg's airway management. Elsevier.
Halayko, A. J., Salari, H., Ma, X., & Stephens, N. L. (1996). Markers of airway smooth muscle cell phenotype. The American Journal of Physiology, 270, L1040–L1051. https://doi.org/10.1152/AJPLUNG.1996.270.6.L1040
Harrington, L. S., Lucas, R., McMaster, S. K., Moreno, L., Scadding, G., Warner, T. D., & Mitchell, J. A. (2008). COX‐1, and not COX‐2 activity, regulates airway function: Relevance to aspirin‐sensitive asthma. The FASEB Journal, 22, 4005–4010. https://doi.org/10.1096/FJ.08‐107979
Hasleton, P. S., Flieder, D. B., & Spencer, H. (2012). Spencer's pathology of the lung. Cambridge University Press.
Hempel, S. L., Monick, M. M., & Hunninghake, G. W. (1994). Lipopolysaccharide induces prostaglandin H synthase‐2 protein and mRNA in human alveolar macrophages and blood monocytes. The Journal of Clinical Investigation, 93, 391–396. https://doi.org/10.1172/JCI116971
Herting, E., & Robertson, B. (2005). Surfactant treatment for inflammatory lung disease. In Lung surfactant function and disorder (pp. 429–454). CRC Press.
Hills, B. A. (1996). Asthma: Is there an airway receptor barrier? Thorax, 51, 773–776. https://doi.org/10.1136/THX.51.8.773
Hills, B. A., & Chen, Y. (2000). Suppression of neural activity of bronchial irritant receptors by surface‐active phospholipid in comparison with topical drugs commonly prescribed for asthma. Clinical & Experimental Allergy, 30, 1266–1274. https://doi.org/10.1046/J.1365‐2222.2000.00850.X
Hills, B. A., Chen, Y., & Hills, Y. C. (2003). Adsorption of surfactant to bronchial epithelium: Possible role of receptor “unmasking” in asthma. The Journal of Asthma, 40, 445–450. https://doi.org/10.1081/JAS‐120018784
Hohlfeld, J. M. (2002). The role of surfactant in asthma. Respiratory Research, 3, 1–8. https://doi.org/10.1186/RR176
Hohlfeld, J. M., Ahlf, K., Enhorning, G., Balke, K., Erpenbeck, V. J., Petschallies, J., Hoymann, H. G., Fabel, H., & Krug, N. (1999). Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge. American Journal of Respiratory and Critical Care Medicine, 159, 1803–1809. https://doi.org/10.1164/ajrccm.159.6.9806145
Hohlfeld, J. M., Hoymann, H., Molthan, J., Fabel, H., & Heinrich, U. (1997). Aerosolized surfactant inhibits acetylcholine‐induced airway obstruction in rats. European Respiratory Journal, 10, 2198. https://doi.org/10.1183/09031936.97.10102198
Islam, M. N., Gusarova, G. A., Das, S. R., Li, L., Monma, E., Anjaneyulu, M., Mthunzi, L., Quadri, S. K., Owusu‐Ansah, E., Bhattacharya, S., & Bhattacharya, J. (2022). The mitochondrial calcium uniporter of pulmonary type 2 cells determines severity of acute lung injury. Nature Communications, 13, 1–15. https://doi.org/10.1038/s41467‐022‐33543‐y
Jo, Y. Y., Kim, K. H., & Kil, H. K. (2013). Negative pressure pulmonary edema related to bronchospasm during anesthetic recovery. Korean Journal of Anesthesiology, 65, 91–92. https://doi.org/10.4097/KJAE.2013.65.1.91
Joshi, R., Hamed, O., Yan, D., Michi, A. N., Mostafa, M. M., Wiehler, S., Newton, R., & Giembycz, M. A. (2021). Prostanoid receptors of the EP4‐subtype mediate gene expression changes in human airway epithelial cells with potential anti‐inflammatory activity. Journal of Pharmacology and Experimental Therapeutics, 376, 161–180. https://doi.org/10.1124/JPET.120.000196
Khan, M. A. (2013). Inflammation signals airway smooth muscle cell proliferation in asthma pathogenesis. Multidisciplinary Respiratory Medicine, 8, 1–5. https://doi.org/10.1186/2049‐6958‐8‐11
Kim, N. H., Kim, K. S., Shin, S. C., Kim, E. E., & Yu, Y. G. (2021). Functional expression of human prostaglandin E2 receptor 4 (EP4) in E. coli and characterization of the binding property of EP4 with Gα proteins. Biochemistry and Biophysics Reports, 25, 1–6. https://doi.org/10.1016/j.bbrep.2020.100871
Koetzler, R., Saifeddine, M., Yu, Z., Schürch, F. S., Hollenberg, M. D., & Green, F. H. Y. (2006). Surfactant as an airway smooth muscle relaxant. American Journal of Respiratory Cell and Molecular Biology, 34, 609–615. https://doi.org/10.1165/rcmb.2005‐0228OC
Konya, V., Marsche, G., Schuligoi, R., & Heinemann, A. (2013). E‐type prostanoid receptor 4 (EP4) in disease and therapy. Pharmacology & Therapeutics, 138, 485–502. https://doi.org/10.1016/j.pharmthera.2013.03.006
Kountz, T. S., Jairaman, A., Kountz, C. D., Stauderman, K. A., Schleimer, R. P., & Prakriya, M. (2021). Differential regulation of ATP‐ and UTP‐evoked prostaglandin E2 and IL‐6 production from human airway epithelial cells. The Journal of Immunology, 207, 1275–1287. https://doi.org/10.4049/JIMMUNOL.2100127
Kozlova, E., Akulova, A., Stepanova, O., Shapovalov, K., Lukyanov, S., & Rosenberg, O. (2018). Surfactant therapy in patients with severe uncontrolled bronchial asthma. European Respiratory Journal, 52, OA1922. https://doi.org/10.1183/13993003.CONGRESS‐2018.OA1922
Kraneveld, A. D., van Ark, I., van der Linde, H. J., Fattah, D., Nijkamp, F. P., & van Oosterhout, A. J. M. (1997). Antibody to very late activation antigen 4 prevents interleukin‐5‐induced airway hyperresponsiveness and eosinophil infiltration in the airways of Guinea pigs. Journal of Allergy and Clinical Immunology, 100, 242–250. https://doi.org/10.1016/S0091‐6749(97)70231‐8
Kurashima, K., Fujimura, M., Tsujiura, M., & Matsuda, T. (1997). Effect of surfactant inhalation on allergic bronchoconstriction in Guinea pigs. Clinical & Experimental Allergy, 27, 337–342. https://doi.org/10.1111/J.1365‐2222.1997.TB00713.X
Liu, M., Wang, L., Li, E., & Enhorning, G. (1996). Pulmonary surfactant given prophylactically alleviates an asthma attack in Guinea‐pigs. Clinical & Experimental Allergy, 26, 270–275. https://doi.org/10.1111/J.1365‐2222.1996.TB00091.X
López Bernal, A., & Phizackerley, P. J. R. (2000). Fetal surfactant as a source of arachidonate in human amniotic fluid. Prostaglandins & Other Lipid Mediators, 60, 59–70. https://doi.org/10.1016/S0090‐6980(99)00050‐7
Loring, S. H. (2017). Communications between pulmonary airways and blood vessels: A new mechanism? American Journal of Respiratory and Critical Care Medicine, 196, 799–800. https://doi.org/10.1164/RCCM.201706‐1260ED
Matthay, M. A., Zemans, R. L., Zimmerman, G. A., Arabi, Y. M., Beitler, J. R., Mercat, A., Herridge, M., Randolph, A. G., & Calfee, C. S. (2019). Acute respiratory distress syndrome. Nature Reviews. Disease Primers, 5, 1–22. https://doi.org/10.1038/s41572‐019‐0069‐0
Meyrick, B., Hoover, R., Jones, M. R., Berry, L. C., & Brigham, K. L. (1989). In vitro effects of endotoxin on bovine and sheep lung microvascular and pulmonary artery endothelial cells. Journal of Cellular Physiology, 138, 165–174. https://doi.org/10.1002/JCP.1041380122
Mills, P. C., Chen, Y., Hills, Y. C., & Hills, B. A. (2005). Differences in surfactant lipids collected from pleural and pulmonary lining fluids. Pharmaceutical Research, 22, 1926–1930. https://doi.org/10.1007/S11095‐005‐7677‐Y
Mizuta, K., Mizuta, F., Xu, D., Masaki, E., Panettieri, R. A., & Emala, C. W. (2011). Gi‐coupled γ‐aminobutyric acid‐B receptors cross‐regulate phospholipase C and calcium in airway smooth muscle. American Journal of Respiratory Cell and Molecular Biology, 45, 1232–1238. https://doi.org/10.1165/RCMB.2011‐0088OC
Mokry, J., Mokra, D., Nosalova, G., Beharkova, M., & Feherova, Z. (2008). Influence of selective inhibitors of phosphodiesterase 3 and 4 on cough and airway reactivity. Journal of Physiology and Pharmacology, 59, 473–482.
Narumiya, S. (2007). Physiology and pathophysiology of prostanoid receptors. Proceedings of the Japan Academy. Series B, Physical and Biological Sciences, 83, 296–319. https://doi.org/10.2183/PJAB/83.296
Obeidat, M., Li, X., Burgess, S., Zhou, G., Fishbane, N., Hansel, N. N., Bossé, Y., Joubert, P., Hao, K., Nickle, D. C., van den Berge, M., Timens, W., Cho, M. H., Hobbs, B. D., de Jong, K., Boezen, M., Hung, R. J., Rafaels, N., Mathias, R., … Sin, D. D. (2017). Surfactant protein D is a causal risk factor for COPD: Results of mendelian randomisation. European Respiratory Journal, 50, 1700657. https://doi.org/10.1183/13993003.00657‐2017
Ohki, Y., Tokuyama, K., Sato, A., Nishimura, H., Tabata, M., Tomiyoshi, K., Inoue, T., Arakawa, H., Kato, M., Mochizuki, H., & Morikawa, A. (2002). Maturational changes in airway remodeling after chronic exposure to ovalbumin in sensitized Guinea pigs: Role of cell renewal of airway resident cells. Pediatric Research, 52, 525–532. https://doi.org/10.1203/00006450‐200210000‐00011
Ohtsuka, T., Lee, H. C., Yamaguchi, M., & Mori, N. (1990). Dipalmitoylphosphatidylcholine (L‐alpha‐lecithin) stimulates prostaglandin E production in human amnion. British Journal of Obstetrics and Gynaecology, 97, 843–846. https://doi.org/10.1111/J.1471‐0528.1990.TB02581.X
Pang, L., & Knox, A. J. (1997). PGE2 release by bradykinin in human airway smooth muscle cells: Involvement of cyclooxygenase‐2 induction. American Journal of Physiology. Lung Cellular and Molecular Physiology, 273, 1132–1140. https://doi.org/10.1152/AJPLUNG.1997.273.6.L1132
Pascual, R. M., Awsare, B. K., Farber, S. A., Panettieri, R. A., Peters, S. P., & Penn, R. B. (2003). Regulation of phospholipase A2 by interleulin‐1 in human airway smooth muscle. Chest, 123, 433S–434S.
Pavord, I. D., & Tattersfield, A. E. (1995). Bronchoprotective role for endogenous prostaglandin E2. Lancet, 345, 436–438. https://doi.org/10.1016/S0140‐6736(95)90409‐3
Peebles, R. S. (2019). Prostaglandins in asthma and allergic diseases. Pharmacology & Therapeutics, 193, 1–19. https://doi.org/10.1016/J.PHARMTHERA.2018.08.001
Rhee, S. G., & Bae, Y. S. (1997). Regulation of phosphoinositide‐specific phospholipase C isozymes. Journal of Biological Chemistry, 272, 15045–15048. https://doi.org/10.1074/jbc.272.24.15045
Säfholm, J., Dahlén, S. E., Delin, I., Maxey, K., Stark, K., Cardell, L. O., & Adner, M. (2013). PGE2 maintains the tone of the Guinea pig trachea through a balance between activation of contractile EP1 receptors and relaxant EP2 receptors. British Journal of Pharmacology, 168, 794–806. https://doi.org/10.1111/J.1476‐5381.2012.02189.X
Sayers, I., Swan, C., & Hall, I. P. (2006). The effect of beta2‐adrenoceptor agonists on phospholipase C (beta1) signalling in human airway smooth muscle cells. European Journal of Pharmacology, 531, 9–12. https://doi.org/10.1016/J.EJPHAR.2005.11.026
Schäfer, A., & Radmacher, M. (2005). Influence of myosin II activity on stiffness of fibroblast cells. Acta Biomaterialia, 1, 273–280. https://doi.org/10.1016/J.ACTBIO.2005.02.004
Schmidt, L. M., Belvisi, M. G., Bode, K. A., Bauer, J., Schmidt, C., Suchy, M.‐T., Tsikas, D., Scheuerer, J., Lasitschka, F., Gröne, H.‐J., & Dalpke, A. H. (2011). Bronchial epithelial cell‐derived prostaglandin E2 dampens the reactivity of dendritic cells. The Journal of Immunology, 186, 2095–2105. https://doi.org/10.4049/JIMMUNOL.1002414
Schmiedl, A., Frank, S., Tschernig, T., & Hohlfeld, J. M. (2023). Ultrastructural analysis of the intracellular surfactant in lungs of healthy and ovalbumin sensitized and challenged Brown Norway rats. Experimental Lung Research, 49, 142–151. https://doi.org/10.1080/01902148.2023.2238232
Schmitz, T., Cox, L. A., Li, C., Levine, B. A., Ford, S. P., McDonald, T. J., & Nathanielsz, P. W. (2007). Prostaglandin E2 receptor expression in fetal baboon lung at 0.7 gestation after betamethasone exposure. Pediatric Research, 61, 421–426. https://doi.org/10.1203/pdr.0b013e318030d141
Shariff, S., Shelfoon, C., Holden, N. S., Traves, S. L., Wiehler, S., Kooi, C., Proud, D., & Leigh, R. (2017). Human rhinovirus infection of epithelial cells modulates airway smooth muscle migration. American Journal of Respiratory Cell and Molecular Biology, 56, 796–803. https://doi.org/10.1165/RCMB.2016‐0252OC
Sheller, J. R., Mitchell, D., Meyrick, B., Oates, J., & Breyer, R. (2000). EP2 receptor mediates bronchodilation by PGE2 in mice. Journal of Applied Physiology, 88, 2214–2218. https://doi.org/10.1152/JAPPL.2000.88.6.2214
Snashall, P. D., & Chung, K. F. (2012). Airway obstruction and bronchial hyperresponsiveness in left ventricular failure and mitral stenosis. American Review of Respiratory Disease, 144, 945–956. https://doi.org/10.1164/AJRCCM/144.4.945
The Lancet. (2020). Global burden of disease: GBD cause and risk summaries. Asthma—Level 3 cause. https://www.thelancet.com/gbd/summaries
Thomas, G., Burnham, N. A., Camesano, T. A., & Wen, Q. (2013). Measuring the mechanical properties of living cells using atomic force microscopy. Journal of Visualized Experiments, 76, 1–8. https://doi.org/10.3791/50497
Topercerova, J., Kolomaznik, M., Kopincova, J., Nova, Z., Urbanova, A., Mokra, D., Mokry, J., & Calkovska, A. (2019). The effect of pulmonary surfactant on the airway smooth muscle after lipopolysaccharide exposure and its mechanisms. Physiological Research, 68, S275–S285. https://doi.org/10.33549/physiolres.934410
Torday, J. S., Qin, J. T., & Sun, H. (1996). Prostaglandin E2 integrates the hormonal‐ and stretch‐stimulated production of surfactant. Pediatric Research, 39, 353. https://doi.org/10.1203/00006450‐199604001‐02125
Tulic, M. K., Christodoulopoulos, P., & Hamid, Q. (2001). Small airway inflammation in asthma. Respiratory Research, 2, 333–339. https://doi.org/10.1186/RR83
van Oosterhout, A. J. M., Ladenius, A. R. C., Savelkoul, H. F. J., van Ark, I., Delsman, K. C., & Nijkamp, F. P. (2012). Effect of anti‐IL‐5 and IL‐5 on airway hyperreactivity and eosinophils in Guinea pigs. American Review of Respiratory Disease, 147, 548–552. https://doi.org/10.1164/AJRCCM/147.3.548
Vancheri, C., Mastruzzo, C., Sortino, M. A., & Crimi, N. (2004). The lung as a privileged site for the beneficial actions of PGE2. Trends in Immunology, 25, 40–46. https://doi.org/10.1016/J.IT.2003.11.001
Warren, K. J., Dickinson, J. D., Nelson, A. J., Wyatt, T. A., Romberger, D. J., & Poole, J. A. (2019). Ovalbumin‐sensitized mice have altered airway inflammation to agriculture organic dust. Respiratory Research, 20, 1–10. https://doi.org/10.1186/S12931‐019‐1015‐0
Webb, R. C. (2003). Smooth muscle contraction and relaxation. American Journal of Physiology. Advances in Physiology Education, 27, 201–206. https://doi.org/10.1152/ADVAN.00025.2003
Widdicombe, J. H., Ueki, I. F., Emery, D., Margolskee, D., Yergey, J., & Nadel, J. A. (1989). Release of cyclooxygenase products from primary cultures of tracheal epithelia of dog and human. Lung Cellular and Molecular Physiology, 257, L361–L365. https://doi.org/10.1152/AJPLUNG.1989.257.6.L361
Wright, J. R. (2003). Pulmonary surfactant: A front line of lung host defense. Journal of Clinical Investigation, 111, 1453–1455. https://doi.org/10.1172/JCI18650
Zeiger, R. S., Schatz, M., Dalal, A. A., Qian, L., Chen, W., Ngor, E. W., Suruki, R. Y., & Kawatkar, A. A. (2016). Utilization and costs of severe uncontrolled asthma in a managed‐care setting. Journal of Allergy and Clinical Immunology. In Practice, 4, 120–129.e3. https://doi.org/10.1016/J.JAIP.2015.08.003